Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov interface version is reflected in the page footer, moving from revision v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added; Revision: v3.5.0 deleted.
    Difference
    0.1%
    Check dated 2026-04-17T13:48:06.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:36.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the history and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:06:03.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page history shows a new revision (v3.4.2) and removal of the previous revision (v3.4.1), indicating a minor platform update with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:42.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A new revision tag, v3.4.1, was added to the history, replacing v3.4.0, which is a minor update with no changes to study data or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:32:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.